<DOC>
	<DOCNO>NCT02866825</DOCNO>
	<brief_summary>The trial enroll patient undergo complex cardiac surgery . The primary goal trial evaluate pharmacodynamic dose response relationship monoclonal antibody IFX-1 patient . In addition , trial aim characterize safety pharmacokinetics IFX-1 well collect first data efficacy clinical surrogate endpoint .</brief_summary>
	<brief_title>Studying Complement Inhibition Complex Cardiac Surgery</brief_title>
	<detailed_description />
	<mesh_term>Systemic Inflammatory Response Syndrome</mesh_term>
	<criteria>1 . Male female patient ≥ 18 year old 2 . Written inform consent 3 . One follow cardiac surgical procedure plan Cardiopulmonary bypass ( CPB ) : Single valve surgery combination least two coronary artery bypass graft ( CABGs ) Multiple valve surgery without CABG Single multiple valve surgery combination ascend aorta procedure without additional CABG Resurgery aortic valve , mitral valve , aortic arch ascend aorta without CABG 4 . Cardiac surgery perform electively 1 . Weight &gt; 130 kg 2 . The following cardiac surgical procedure : Cardiac surgical procedure plan minimally invasive procedure ( e.g. , without thoracotomy lateral incision , minimal thoracotomy ) Cardiac surgery expect CPB time le 100 minute 3 . Other cardiac vascular disease and/or procedure : Prior cardiac surgery within past 6 month History heart transplantation plan heart transplantation Requiring inotropic , vasopressor mechanical circulatory support Requiring ventilatory support 4 . Other disease condition likely interfere evaluation study drug : Active infective endocarditis Stroke transient ischemic attack ( TIA ) within last 6 month Concomitant disease life expectancy le 6 month Cardiopulmonary resuscitation within last 4 week Patients require renal replacement therapy 5 . Cerebrovascular disease require concomitant carotid endarterectomy 6 . Active infection without temperature great 38°C 7 . Presence systemic inflammatory response syndrome define occurrence least 2 follow 4 criterion : Fever &gt; 38.0°C hypothermia &lt; 36.0°C Tachycardia &gt; 90 beats/minute Tachypnea &gt; 20 breaths/minute Leucocytosis &gt; 12 x 109/l leucopenia &lt; 4 x 109/l &gt; 10 % immature neutrophil ( band ) 8 . Positive test human immunodeficiency virus ( HIV ) , hepatitis B C 9 . One follow abnormal laboratory result : Hemoglobin &lt; 5 mmol/l ( &lt; 8.06 g/dl ) Total bilirubin ≥ 2 x upper normal limit ( UNL ) CRP &gt; 3 x UNL ALAT &gt; 3 x UNL ASAT &gt; 3 x UNL White blood cell count &lt; 2,500/mm³ White blood cell count &gt; 12,000/mm³ 10 . Prohibited concomitant medication : Immunomodulatory drug within past 30 day ( e.g. , TNFinhibitors ) Immunosuppressive drug within past 30 day ( e.g. , cyclosporine , tacrolimus ) High dose corticosteroid ( e.g. , &gt; 50 mg prednisone/day equivalent ) within past 14 day Any systemic anticancer treatment within past 3 month 11 . Planned corticosteroid pulse therapy prevent SIRS 12 . Patients know hypersensitivity constituent investigational medicinal product ( IMP ) 13 . General exclusion criterion : Pregnant ( woman childbearing potential urine pregnancy test perform ) breastfeed woman Women childbearing potential ( define within two year last menstruation ) willing practice appropriate contraceptive measure ( e.g. , implanon , injection , oral contraceptive , intrauterine device , partner vasectomy , abstinence ) participate trial Participation interventional clinical trial within last three month Prior randomization clinical trial ( screen failure rescreened , appropriate ) Alcohol , drug , medication abuse Employee study site , spouse/partner relative study staff ( e.g. , investigator , subinvestigators , study nurse ) relationship sponsor No commitment full aggressive life support ( e.g. , DNR order )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Inflammation</keyword>
	<keyword>Systemic Inflammatory Response Syndrome</keyword>
	<keyword>Pathologic Processes</keyword>
	<keyword>Organ Dysfunction</keyword>
</DOC>